Inflammation is a major pathological process underlying numerous chronic diseases, highlighting the need for anti-inflammatory inhibitors from nature. This study investigated the anti-inflammatory potential of S. praecox leaf extracts and elucidated molecular mechanisms through an integrated experimental and computational approach. As a result, the 75% methanol extract (75M) inhibited tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) production in lipopolysaccharide (LPS)-stimulated RAW264.7. Untargeted metabolomic analysis led to the tentative identification of 96 metabolites, predominantly flavonoids, terpenoids, ellagitannins, fatty acids, and phenolic acids. Network pharmacology analysis of overlapping targets suggested TNF and IL6 emerging as crucial hub genes. Functional enrichment analyses further revealed significant involvement of inflammatory pathways. ADMET screening suggested potentially favorable predicted ADMET characteristics. Molecular docking predicted favorable binding energies between constituents and inflammatory targets. Experimental validation showed that the 75M extract significantly inhibited NF-κB activation by suppressing IκBα and p65 phosphorylation. Furthermore, the extract attenuated MAPK signaling by inhibiting ERK1/2 and p38 phosphorylation. These findings suggest that S. praecox exerts potent anti-inflammatory activity through a multi-component, multi-target mechanism involving the coordinated regulation of the NF-κB and MAPK signaling pathways, thereby providing a therapeutic basis for further investigation of S. praecox as a promising candidate for treating inflammation.